-
NIH Exec: Research Offers Opioid Crisis Solutions
The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths.
-
Cancer Analytics Company Acquired in $1.9B Deal
The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion.
-
Going to Austin, City with No Limits
Science & Enterprise is headed to Austin, Texas to cover the annual meeting of American Association for the Advancement of Science, or AAAS, and we will report from the meeting from Friday through Sunday.
-
FDA Clears First Blood Test for Concussions
The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury.
-
Lab Burns Graphene Circuits into Food, Fabrics
A chemistry lab at Rice University devised a process for producing graphene, a material that conducts electricity, in materials containing carbon, including fabrics and even food.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.
-
Engineered Virus Shows Promise in Some Brain Tumors
A clinical trial testing a common virus modified to generate a specific immune response dramatically reduced deadly brain tumors in a small group of patients and extended their survival for years, but most other patients had only limited success.
-
Cardiac Augmented-Reality Hologram System in Development
A start-up company spun-off from Washington University in St. Louis was awarded a grant to advance an augmented reality system that displays an interactive hologram of a patient’s heart, to simplify cardiac procedures.
-
Report – Industry Pain, Addiction Drug Efforts Flagging
A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society.
-
Infographic – Software Security Risks at Record Level
This weekend’s infographic is from our friends at Statista who published a recent chart showing the almost constant rise in security risks since 2010 due to software, recorded by Hasso-Plattner-Institute in Germany.